BRLI completes equity investment in InCellDx
 

Bio-Reference Laboratories, Inc. announced today that it has completed an equity investment in InCellDx, Inc., a privately held molecular diagnostics start-up company dedicated to the detection and monitoring of life -threatening diseases such as cervical cancer, breast cancer, HIV/AIDs, hepatitis and organ transplant rejection.

More...